Media & Resources

NEW YORK, May 12, 2011—The International AIDS Vaccine Initiative (IAVI) welcomes the news that a large, multinational clinical study led by the HIV Prevention Trials Network (HPTN) has demonstrated that oral antiretroviral therapy (ART) administered earlier in the course of infection can reduce the sexual transmission of HIV among discordant couples, or couples in which…

The International AIDS Vaccine Initiative is pleased to announce the launch of its Fellowship Program in AIDS Vaccine Research and Development. This new program offers a unique opportunity for talented, young and early-career post-doctoral candidates to train alongside leading scientists in the AIDS vaccine field and contribute to one of the greatest global health challenges…

NEW YORK, April 18, 2011 – Sponsors of the pre-exposure prophylaxis (PrEP) clinical trial FEM-PrEP announced today that following a scheduled interim review of study data, the Independent Data Monitoring Committee advised that the trial will be highly unlikely to determine that the study drug regimen decreased risk of HIV infection among HIV-negative women at risk…

Forty AIDS and global health organizations from around the world, including the International AIDS Vaccine Initiative (IAVI), have endorsed a call for the United Nations High-Level Meeting on the Comprehensive Review on HIV/AIDS to make a firm commitment on research, development and delivery of new HIV-prevention options. The endorsing organizations proposed the following language be…

Seth Berkley Named as New GAVI Chief NEW YORK, March 8, 2011 – The International AIDS Vaccine Initiative (IAVI) congratulates its founder, President and Chief Executive Officer Seth Berkley on his appointment as Chief Executive Officer of the Global Alliance for Vaccines and Immunization (GAVI). The Board of GAVI, an organization that increases access to immunization…

NEW DELHI, March 3, 2011—The Translational Health Sciences and Technology Institute (THSTI), an autonomous institute of the Indian government’s Department of Biotechnology, and the International AIDS Vaccine Initiative (IAVI) announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Programme in India. The program will include the establishment of a new…

Phase I Clinical Trial to Test Combination of Two Experimental HIV Vaccine Components New York, February 28, 2011 – The International AIDS Vaccine Initiative (IAVI) today announces the start of a multi-center Phase I trial in Africa to evaluate the safety and immunogenicity of a preventive AIDS vaccine candidate made up of two components. The trial,…

New York, February 4, 2011 – IAVI is distressed and saddened by the tragic murder in Uganda last week of David Kato, an activist in the fight against AIDS and for the rights of sexual minorities in Africa. Three decades of experience with HIV/AIDS have clearly demonstrated that stigma is a barrier to effective responses to…